Found: 87
Select item for more details and to access through your institution.
CMR 2005: 11.03: Current concepts in the evaluation of immediate allergic reactions to contrast agents.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 80, doi. 10.1002/cmmi.62
- By:
- Publication type:
- Article
CMR 2005: 7.02: Exploring microvessels using intravital fluorescence microscopy: role of molecular weight of agents.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 70, doi. 10.1002/cmmi.40
- By:
- Publication type:
- Article
CMR 2005: 14.01: In vivo structural and functional imaging of the mouse spinal cord using manganese-enhanced MRI.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 89, doi. 10.1002/cmmi.80
- By:
- Publication type:
- Article
CMR 2005: 8.06: Contrast-assisted ultrasound for sentinel lymph node detection; the effect of particle characteristics and node status on imaging efficacy.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 75, doi. 10.1002/cmmi.51
- By:
- Publication type:
- Article
CMR 2005: 14.05: First use of intra-articular carbon dioxide for MR arthrography; a feasibility study.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 91, doi. 10.1002/cmmi.84
- By:
- Publication type:
- Article
CMR 2005: 5.05: The risk of contrast medium-induced nephropathy should be correlated with the ratio between dose in grams of iodine and estimated glomerular filtration rate.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 67, doi. 10.1002/cmmi.33
- By:
- Publication type:
- Article
CMR 2005: 13.01: Mannosyl-dextran: a potential multi-modality contrast agent targeting at mannose receptor.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 86, doi. 10.1002/cmmi.73
- By:
- Publication type:
- Article
CMR 2005: 2.04: MRI of cerebral ischemia with ultra-small superparamagnetic particles of iron oxide in mice.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 55, doi. 10.1002/cmmi.11
- By:
- Publication type:
- Article
CMR 2005: 7.06: Role of perfusion CT in monitoring anti-angiogenic response in patients with advanced hepatocellular carcinoma.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 72, doi. 10.1002/cmmi.44
- By:
- Publication type:
- Article
CMR 2005: 3.09: Preclinical efficacy of <sup>177</sup>Lu-AMBA, a radiotherapeutic targeting the GRP receptor.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 61, doi. 10.1002/cmmi.22
- By:
- Publication type:
- Article
CMR 2005: 3.02: The stromal mechanism: an inherent link between necrosis-avid contrast agents and photodynamic therapy.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 57, doi. 10.1002/cmmi.15
- By:
- Publication type:
- Article
CMR 2005: 12.01: High-resolution x-ray microtomography of spleen in living mice.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 82, doi. 10.1002/cmmi.66
- By:
- Publication type:
- Article
CMR 2005: 11.02: Vector-electrocardiographic changes in pigs indicating risk of ventricular fibrillation after injections into the left coronary artery of mannitol or iodixanol solutions with or without electrolytes.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 80, doi. 10.1002/cmmi.61
- By:
- Publication type:
- Article
CMR 2005: 3.06: PEGylated and fluorescent superparamagnetic liposomes provide a promising tool for combining in vivo imaging and therapy.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 59, doi. 10.1002/cmmi.19
- By:
- Publication type:
- Article
CMR 2005: 9.03: Novel magnetic resonance contrast mechanism for combined tracking of the delivery of mesenchymal stem cells and interventional devices.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 76, doi. 10.1002/cmmi.55
- By:
- Publication type:
- Article
CMR 2005: 4.05: Ultra-small supraparamagnetic iron oxide-enhanced MR imaging of antigen-induced arthritis: a comparative study between SH U 555 C, ferumoxtran-10 and ferumoxytol.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 63, doi. 10.1002/cmmi.27
- By:
- Publication type:
- Article
CMR 2005: 3.08: Preliminary imaging results with NM404 in lung cancer patients.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 60, doi. 10.1002/cmmi.21
- By:
- Publication type:
- Article
CMR 2005: 4.04: Folate-targeted high-relaxivity gadolinium chelate: in vitro binding affinity evaluation on purified folate-binding protein and on KB tumor cells overexpressing folate receptors.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 62, doi. 10.1002/cmmi.26
- By:
- Publication type:
- Article
CMR 2005: 2.01: High-field MRA with iron oxide blood-pool contrast agents: field strength effects on vascular contrast enhancement in rabbits at 1.5 and 3.0 T.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 54, doi. 10.1002/cmmi.8
- By:
- Publication type:
- Article
CMR 2005: 6.04: Blood-pool contrast medium (Vistarem) discriminates acutely infarcted from scarred myocardium on late enhancement.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 69, doi. 10.1002/cmmi.37
- By:
- Publication type:
- Article
CMR 2005: 13.05: A temperature-sensitive contrast mechanism for MRI: Curie temperature transition-based imaging.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 88, doi. 10.1002/cmmi.77
- By:
- Publication type:
- Article
CMR 2005: 8.03: Targeted ultrasound contrast agents for molecular imaging in high-shear flow.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 74, doi. 10.1002/cmmi.48
- By:
- Publication type:
- Article
CMR 2005: 3.01: MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctylmannose conjugate (Gadofluorine M), a novel protein-avid contrast agent.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 57, doi. 10.1002/cmmi.14
- By:
- Publication type:
- Article
CMR 2005: 9.07: In vivo MR tracking of magnetically labeled dendritic cells: first clinical experience.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 79, doi. 10.1002/cmmi.59
- By:
- Publication type:
- Article
CMR 2005: 1.03: Analysis of hepatic uptake of anionic magnetic nanoparticles.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 52, doi. 10.1002/cmmi.4
- By:
- Publication type:
- Article
CMR 2005: 14.04: Oral manganese as contrast medium in detecting liver metastases with MR imaging at 1.5 and 3 T.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 90, doi. 10.1002/cmmi.83
- By:
- Publication type:
- Article
CMR 2005: 2.03: VSOP-C184 as contrast agent for MRI of atherosclerotic plaques: experimental results in rabbits.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 55, doi. 10.1002/cmmi.10
- By:
- Publication type:
- Article
CMR 2005: 8.05: Effects of high MI exposure during contrast echocardiography with SonoVue™ in the dog.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 74, doi. 10.1002/cmmi.50
- By:
- Publication type:
- Article
CMR 2005: 5.04: Dendrimer-based nano-sized contrast agents for functional renal MRI: new insights into pathogenesis of acute renal diseases.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 66, doi. 10.1002/cmmi.32
- By:
- Publication type:
- Article
CMR 2005: 12.07: In vivo magnetic resonance imaging: use of extracellular contrast agent to quantify the efficiency and the toxicity of gene electrotransfer in rat muscle.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 85, doi. 10.1002/cmmi.72
- By:
- Publication type:
- Article
CMR 2005: 7.05: Contrast-enhanced ultrasound and CT for quantifying response to anti-angiogenic therapy in a rat tumor model.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 71, doi. 10.1002/cmmi.43
- By:
- Publication type:
- Article
CMR 2005: 9.02: Detection of single cells by high-field MRI.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 76, doi. 10.1002/cmmi.54
- By:
- Publication type:
- Article
CMR 2005: 11.06: European multicenter study on contrast media hypersensitivity.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 82, doi. 10.1002/cmmi.65
- By:
- Publication type:
- Article
CMR 2005: 1.01: The hepatobiliary excretion of Gd-BOPTA does not interfere with the clearance of other drugs.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 52, doi. 10.1002/cmmi.2
- By:
- Publication type:
- Article
CMR 2005: 1.05: Does dual-contrast MRI of the liver improve the detection of focal liver lesions? On-site results of a prospective multicenter study.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 53, doi. 10.1002/cmmi.6
- By:
- Publication type:
- Article
CMR 2005: 12.02: Micro-CT and micro-DSA of small animal models of disease using iodinated conventional and blood pool contrast agents.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 83, doi. 10.1002/cmmi.67
- By:
- Publication type:
- Article
CMR 2005: 4.03: A new contrast agent for magnetic resonance imaging of the vascular walls.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 62, doi. 10.1002/cmmi.25
- By:
- Publication type:
- Article
CMR 2005: 6.03: The efficacy of MultiHance (gadobenate dimeglumine or Gd-BOPTA) at 1.5 and 3 T in a rat brain glioma model.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 68, doi. 10.1002/cmmi.36
- By:
- Publication type:
- Article
CMR 2005: 13.04: Design and pharmacomodulation of high-relaxivity MR contrast agents.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 87, doi. 10.1002/cmmi.76
- By:
- Publication type:
- Article
CMR 2005: 8.02: Fibrin-directed nanoparticles for combined imaging and local thrombolytic therapy.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 73, doi. 10.1002/cmmi.47
- By:
- Publication type:
- Article
CMR 2005: 9.06: Iron oxide nanoparticles as a cell labeling contrast agent for non-invasive long-term cell therapy monitoring by MRI: an abdominal aortic aneurysm model.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 78, doi. 10.1002/cmmi.58
- By:
- Publication type:
- Article
CMR 2005: 3.05: In vivo follow-up of Gd-labeled liposome concentrations in rats bearing a glioma: a comparative study.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 59, doi. 10.1002/cmmi.18
- By:
- Publication type:
- Article
Current Awareness in Contrast Media and Molecular Imaging.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 93, doi. 10.1002/cmmi.98
- Publication type:
- Article
CMR 2005: 5.01: Diagnostic imaging with iobitridol: safety in a general population and tolerance in patients with rare risk factors. results in 52 057 patients.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 63, doi. 10.1002/cmmi.29
- By:
- Publication type:
- Article
CMR 2005: 12.04: Stealthy magnetophages, a new tool for molecular imaging.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 84, doi. 10.1002/cmmi.69
- By:
- Publication type:
- Article
CMR 2005: 1.06: Comparison of liver metastasis detectability from colorectal cancer between SPIO-MRI and diffusion-weighted imaging: how and when should SPIO-MRI be applied?
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 54, doi. 10.1002/cmmi.7
- By:
- Publication type:
- Article
CMR 2005: 1.02: Extraction rate of SPIO by the normal and gadolinium chloride-treated liver.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 52, doi. 10.1002/cmmi.3
- By:
- Publication type:
- Article
CMR 2005: 3.07: High-Z compounds for synchrotron stereotactic radiotherapy: developments and perspectives.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 60, doi. 10.1002/cmmi.20
- By:
- Publication type:
- Article
CMR 2005: 5.03: Effect of bicarbonate infusion on contrast-induced nephropathy.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 64, doi. 10.1002/cmmi.31
- By:
- Publication type:
- Article
CMR 2005: 11.01: Radiodiagnostic examinations with iodinated contrast media may result in severe DNA damage resulting in cellular radiosensitization.
- Published in:
- Contrast Media & Molecular Imaging, 2006, v. 1, n. 2, p. 79, doi. 10.1002/cmmi.60
- By:
- Publication type:
- Article